ASST Santi Paolo e Carlo - Ospedale San Carlo Borromeo

Milan 20142

1 studies enrolling now · 2 studies all time

What they study most

End Stage Kidney Disease, Non-Small Cell Lung Cancer

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer — Completed